EP4566674
ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOF
Status:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á ÍslandiEP appl. date:
27.12.2021EP published:
20.5.2026EP application number:
25158879.4
EPO information:
European Patent Register
Max expiry date:
26.12.2041Expiry date:
26.12.2026
Title in English:
ANTIBODY COMPOSITIONS AND METHODS OF USE THEREOFLanguage of the patent:
English
Timeline
Today
27.12.2021EP application
20.5.2026EP Publication
26.12.2026Expires
Owner
Name:
Bristol-Myers Squibb CompanyAddress:
Route 206 and Province Line Road, Princeton, NJ 08543, US
Name:
Halozyme, Inc.Address:
12390 El Camino Real, San Diego, CA 92130, US
Inventor
Name:
HUANG, MasanoAddress:
Princeton, 08543, US
Name:
KHOSSRAVI, MehrnazAddress:
Princeton, 08543, US
Name:
HABY, Thomas ArthurAddress:
Lincroft, 07738, US
Name:
HART, Scott AaronAddress:
Princeton, 08543, US
Name:
MANTRI, Rao VenkatramanaAddress:
Princeton, 08543, US
Name:
VEZINA, Heather ElizabethAddress:
Princeton, 08543, US
Name:
ROY, AmitAddress:
Princeton, 08543, US
Name:
MURTHY, Bindu PurnimaAddress:
Princeton, 08543, US
Name:
ARAS, Urvi AshishAddress:
Princeton, 08543, US
Name:
SANGHAVI, KinjalAddress:
Princeton, 08543, US
Name:
ZHAO, XiaochenAddress:
Princeton, 08543, US
Name:
BELLO, AkintundeAddress:
Princeton, 08543, US
Priority
Number:
202063131234 PDate:
28.12.2020Country:
US
Number:
202063131244 PDate:
28.12.2020Country:
US
Number:
202163150465 PDate:
17.2.2021Country:
US
Classification
Categories:
A61K 9/00, A61K 38/47, A61K 39/395, A61K 47/18, A61K 47/20, A61K 47/26, A61P 31/00, A61P 35/00, A61K 38/00, A61K 39/00, C07K 16/28